Mobilise-D
Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement
- Duración
- 2019-2024
- Coordinador
- Lynn Rochester (Newcastle University)
- Financiadores
- Innovative Medicines Initiative (IMI)
- Página web
- https://www.mobilise-d.eu/
Mobility – how well we walk – is an important marker of health; a slow walking speed is associated with a greater risk of disease, cognitive decline, risk of falls and even earlier death. As the population ages, the number of people experiencing mobility issues is expected to rise. However, accurately assessing people’s mobility, especially in the real world, is far from easy.
MOBILISE-D aims to develop a comprehensive system to analyse people’s gait based on digital technologies, including sensors worn on the body. The project focuses on conditions which often affect mobility, namely chronic obstructive pulmonary disease (COPD), Parkinson’s disease, multiple sclerosis, hip fracture recovery, and congestive heart failure.
The project plans to work closely with regulators and other stakeholders to ensure that the solutions are accepted. Once validated, the MOBILISE-D results will help to improve the accurate assessment of mobility in clinical trials. They will also make it easier for clinicians to monitor patients’ mobility and thereby contribute to improved, more personalised caret
Budget
1,597,781 euros (total 24 millions €)
Nuestro equipo
ISGlobal Principal Investigator (PI)
-
Judith Garcia Jefa del programa de Enfermedades No Transmisibles y Medio Ambiente
ISGlobal Team
- Magda Bosch De Basea Investigadora postdoctoral
-
Sarah Koch Investigadora postdoctoral - Laura Delgado Investigadora predoctoral
- Marta Benet Técnica estadística
- Anne-Elie Carsin Técnica estadística
-
Elena Gimeno Project Manager
Otros proyectos
Ver proyectos pasadosMCC-Spain
Estudio multi-caso control poblacional, incluyendo tumores de alta incidencia en España
ALEC
Aging Lungs in European Cohorts
PROactive
Physical Activity as a Crucial Patient Reported Outcome in COPD
QUALI-VERD
Social and environmental determinants of physical activity in patients with chronic obstructive pulmonary disease (COPD): a qualitative and quantitative epidemiological study
OMEGA-NET
Network on the Coordination and Harmonisation of European Occupational Cohorts
Global Assessment of Trihalomethanes in Drinking Water
POLLAR
Impact Of Pollution on Asthma and Rhinitis
CORSAIR
Severe respiratory failure in COVID-19: clinical, biological and imaging risk factors
VEIS
Valorización del Archivo Europeo del Genomas y Fenomas (EGA) para la Industria y la Sociedad
COVICAT
Cohorte Covid-19 en Cataluña
EARLY-ADAPT
Signs of Early Adaptation to Climate Change
AiguaBCN
Exposure to emerging contaminants in drinking water in Barcelona potentially liked to chronic diseases and wellbeing
Fotovoz
Las Voces de los Afectados por la Nefropatía Mesoamericana
Metabolomic Analysis as a Window into the Etiology of Mesoamerican Nephropathy
CALMA
Co-created educational programme for dyspnea-bearing patients and their caregivers
Cancer-Watch
Risk of colorectal and breast cancer with widespread drinking water chemical contaminants
CONTENT
Cohorte de COVID-19 en España: dinámica social, salud mental y desigualdades
EXPANSE
EXposome Powered tools for healthy living in urbAN SEttings
COVAIR-CAT
Air Pollution in Relation to COVID-19 Morbidity and Mortality: A Large Population-Based Cohort Study in Catalonia